Brandtzaeg P, Kierulf P, Gaustad P, Skulberg A, Bruun J N, Halvorsen S, Sørensen E
Department of Infectious Diseases, Ullevål University Hospital, Oslo, Norway.
J Infect Dis. 1989 Feb;159(2):195-204. doi: 10.1093/infdis/159.2.195.
We studied prospectively the quantitative relation of circulating endotoxin (lipooligosaccharides [LOSs]) and the development of multiple organ failure and death in 45 consecutively admitted patients with bacteriologically verified systemic meningococcal disease (SMD). A plasma LOS level of greater than 700 ng/L correlated with development of severe septic shock (P less than .0001), adult respiratory distress syndrome (P = .0035), a pathologically elevated serum creatinine level (P less than .0001), or death as a consequence of multiple organ failure (P = .0002). Initial plasma LOS levels of less than 25, 25-700, 700-10,000, and greater than 10,000 ng/L were associated with 0%, 14%, 27%, and 86% fatality, respectively. The LOS half-life after initiation of antibiotic therapy was 1-3 h. Increasing plasma LOS levels were never seen. These observations suggest that LOS quantitation using the limulus amebocyte lysate assay with a chromogenic substrate gives important progsnotic information and may provide new insight concerning pathophysiological aspects of SMD.
我们前瞻性地研究了45例连续入院且经细菌学证实患有系统性脑膜炎球菌病(SMD)患者循环内毒素(脂寡糖 [LOSs])的定量关系以及多器官功能衰竭和死亡的发生情况。血浆LOS水平大于700 ng/L与严重脓毒性休克的发生相关(P<0.0001)、成人呼吸窘迫综合征(P = 0.0035)、血清肌酐水平病理性升高(P<0.0001)或因多器官功能衰竭导致的死亡(P = 0.0002)。初始血浆LOS水平低于25、25 - 700、700 - 10,000和大于10,000 ng/L分别与0%、14%、27%和86%的死亡率相关。抗生素治疗开始后LOS的半衰期为1 - 3小时。血浆LOS水平从未出现升高。这些观察结果表明,使用显色底物鲎试剂法进行LOS定量可提供重要的预后信息,并可能为SMD的病理生理学方面提供新的见解。